Knoll Capital Management, LLC
MIAMI, FL · CIK 1325083 · 13F filing filed 2021-08-16
No investment adviser registration (Form ADV) found for this filer. It may be a parent company whose subsidiaries are the registered advisers, a bank or insurer, or a manager based outside the US.
- Others nearbyMiami, FL
$191.5m
reported value
+24.8% vs Q1 2021
42positions
83.8%in top 10
0 new
4 added
1 reduced
0 sold out
vs Q1 2021
This manager withheld holdings under SEC confidential treatment in Q1 2021, so positions that look new may have been held then. They're marked "Not comparable".
Holdings, Q2 2021
The small lines show how much was held over the last 4 quarters (adjusted for stock splits).
| Security | Value | Change |
|---|---|---|
| BIOHAVEN PHARMACTL HLDG CO L BHVN | $83.2m43.44% | Unchanged |
| APPLIED THERAPEUTICS INC APLT | $21.4m11.20% | Added +6.7k |
| ENTERA BIO LTD ENTX | $14.9m7.76% | Added +692.9k |
| CORBUS PHARMACEUTICALS HLDGS CRBP | $9.2m4.82% | Unchanged |
| Orgenesis, Inc. COM | $6.7m3.49% | Unchanged |
| ALDEYRA THERAPEUTICS INC ALDX | $6.5m3.37% | Unchanged |
| EIGER BIOPHARMACEUTICALS INC CLDN | $5.9m3.09% | Unchanged |
| Anavex Life Sciemves Corp COM NEW | $4.8m2.52% | Unchanged |
| ABEONA THERAPEUTICS INC COM | $4.5m2.33% | Unchanged |
| ANNOVIS BIO INC ANVS | $3.4m1.75% | Not comparable |
| CENTURYLINK INC CTL | $3.0m1.56% | Unchanged |
| BLACKSTONE GROUP L P BX | $2.9m1.52% | Reduced -10.0k |
| EXICURE INC XCUR | $1.9m1.00% | Unchanged |
| DOW INC DOW | $1.9m0.99% | Unchanged |
| CORTEVA INC CTVA | $1.3m0.70% | Unchanged |
| ARISTA NETWORKS INC COM | $1.2m0.65% | Unchanged |
| CVS HEALTH CORP CVS | $1.2m0.63% | Unchanged |
| DUPONT DE NEMOURS INC DWDP | $1.2m0.61% | Unchanged |
| ADVANCED MICRO DEVICES INC AMD | $1.2m0.61% | Not comparable |
| VISA INC V | $1.1m0.59% | Unchanged |
| ALTIMMUNE INC ALT | $1.1m0.58% | Unchanged |
| VMWARE INC VMW | $1.1m0.58% | Unchanged |
| BOOZ ALLEN HAMILTON HLDG COR BAH | $1.1m0.58% | Unchanged |
| CORNING INC GLW | $1.1m0.57% | Unchanged |
| ALTRIA GROUP INC MO | $1.1m0.57% | Unchanged |
| THERMO FISHER SCIENTIFIC INC TMO | $1.1m0.55% | Unchanged |
| SOLIGENIX INC COM | $874.0k0.46% | Unchanged |
| ANGION BIOMEDICA CORP COM | $781.0k0.41% | Unchanged |
| MAVERIX METALS INC COM NEW | $620.0k0.32% | Unchanged |
| BIOXCEL THERAPEUTICS INC COM | $581.0k0.30% | Unchanged |
| SEABRIDGE GOLD INC COM | $562.0k0.29% | Unchanged |
| FRANCO NEV CORP FNV | $544.0k0.28% | Unchanged |
| OSISKO GOLD ROYALTIES LTD COM | $474.0k0.25% | Unchanged |
| AGNICO EAGLE MINES LTD AEM | $417.0k0.22% | Unchanged |
| KIRKLAND LAKE GOLD LTD KL | $414.0k0.22% | Unchanged |
| APPLIED GENETIC TECHNOLOGIES AGTC | $391.0k0.20% | Not comparable |
| SILVERCORP METALS INC SVM | $384.0k0.20% | Added +33.5k |
| SILVERCREST METALS INC SIL | $367.0k0.19% | Added +11.0k |
| MAG SILVER CORP MAG | $362.0k0.19% | Unchanged |
| EQUINOX GOLD CORP EQX | $316.0k0.17% | Unchanged |
| FORTUNA SILVER MINES INC COM | $253.0k0.13% | Unchanged |
| PAN AMERN SILVER CORP PAAS | $234.0k0.12% | Unchanged |
Stakes above 5%
Companies where this manager has reported owning more than 5% of a class of shares, on Schedule 13D (may seek influence) or 13G (passive): its latest filing for each, from 19 Dec 2024 on.
| Company | Stake |
|---|---|
| ELICIO THERAPEUTICS INC ELTX · 13G · filed 2026-07-08 | 5.3%≈ $4.7m |